https://www.tidemetrix.com/asymchem-expects-higher-peptide-capacity-utilization-in-2027/2026-10-24T09:13:15.000Zhttps://www.tidemetrix.com/dupont-launches-c8-and-c18-silica-media-for-peptide-purification/2026-10-23T13:12:53.000Zhttps://www.tidemetrix.com/sanofi-breaks-ground-on-frankfurt-insulin-api-facility/2026-10-22T16:17:35.000Zhttps://www.tidemetrix.com/zhengguang-details-planned-chinese-peptide-synthesis-resin-capacity/2026-10-22T16:14:54.000Zhttps://www.tidemetrix.com/peptide-industrys-race-to-scale-up-takes-center-stage-at-tides-europe/2026-10-19T10:27:06.000Zhttps://storage.ghost.io/c/8c/3b/8c3b3759-3ac1-440e-8329-58545d63865e/content/images/2026/10/Pharmaceutical-Cleanroom-Reactor-Line.pngPharmaceutical-Cleanroom-Reactor-Line.pnghttps://www.tidemetrix.com/highfine-targets-late-2026-to-early-2027-trials-at-huaian/2026-10-18T13:21:33.000Zhttps://storage.ghost.io/c/8c/3b/8c3b3759-3ac1-440e-8329-58545d63865e/content/images/2026/10/highfine-feature.jpghighfine-feature.jpghttps://www.tidemetrix.com/cordenpharma-completes-ambiopharm-acquisition-bringing-us-and-chinese-sites-into-its-network/2026-10-18T13:20:40.000Zhttps://storage.ghost.io/c/8c/3b/8c3b3759-3ac1-440e-8329-58545d63865e/content/images/2026/10/cordenpharma-feature.jpgcordenpharma-feature.jpghttps://www.tidemetrix.com/polypeptide-tender-meets-minimum-acceptance-condition-on-provisional-results/2026-10-13T09:31:28.000Zhttps://www.tidemetrix.com/the-peptide-capacity-race/2026-10-13T08:44:03.000Zhttps://www.tidemetrix.com/jymeds-hubei-a16-peptide-workshop-targets-november-production/2026-10-11T10:03:23.000Zhttps://www.tidemetrix.com/us-manufacturing-inquiry-includes-oxytocin-vasopressin-and-peptide-starting-materials/2026-10-06T09:44:06.000Zhttps://www.tidemetrix.com/shengnuo-suspends-us-peptide-api-shipments-after-fda-import-alert/2026-10-06T09:39:24.000Zhttps://www.tidemetrix.com/claros-reports-tfa-treatment-pilot-at-bachems-bubendorf-site/2026-10-06T09:26:13.000Zhttps://www.tidemetrix.com/cordenpharma-breaks-ground-on-north-augusta-peptide-expansion-2/2026-10-06T09:22:38.000Zhttps://www.tidemetrix.com/sinopep-disclosure-separates-peptide-design-capacity-from-historical-production/2026-10-06T09:15:18.000Zhttps://www.tidemetrix.com/hanyu-wuhan-reports-approval-for-chemically-synthesized-liraglutide-api/2026-10-06T09:10:49.000Zhttps://www.tidemetrix.com/medtide-reports-multi-tonne-peptide-capacity-in-china-as-rocklin-expansion-advances/2026-10-06T09:07:20.000Zhttps://www.tidemetrix.com/hanyu-wuhan-reports-linaclotide-api-registration-approval/2026-10-06T09:03:04.000Zhttps://www.tidemetrix.com/ambiopharms-north-augusta-expansion-gains-118-96-million-investment-figure-and-end-2027-target/2026-10-06T08:55:59.000Zhttps://www.tidemetrix.com/sunresin-plans-phased-pucheng-production-including-peptide-synthesis-supports/2026-10-06T07:54:36.000Zhttps://www.tidemetrix.com/asymchem-reports-over-45-000-l-of-commissioned-spps-volume-targets-69-000-l-by-year-end/2026-10-06T07:49:16.000Zhttps://www.tidemetrix.com/lupin-links-dabhasa-expansion-to-protected-amino-acids-and-peptide-manufacturing/2026-10-06T07:25:45.000Zhttps://www.tidemetrix.com/harbin-jixianglong-faces-us-import-restrictions-after-semaglutide-api-recall/2026-10-06T07:06:15.000Zhttps://www.tidemetrix.com/neuland-reports-first-peptide-module-operational-as-second-phase-takes-shape/2026-10-05T14:41:38.000Zhttps://www.tidemetrix.com/amylyx-secures-bachem-agreement-and-outlines-polypeptide-avexitide-reservation/2026-10-05T14:25:17.000Zhttps://www.tidemetrix.com/changzhou-peptide-api-project-gains-environmental-approval-startup-depends-on-wastewater-infrastructure/2026-10-05T13:55:52.000Z